Tag

Screening

All articles tagged with #screening

TRICARE Expands Skin-Cancer Screening and Prevention Resources
health1 day ago

TRICARE Expands Skin-Cancer Screening and Prevention Resources

TRICARE covers skin cancer screening as part of its annual Health Promotion and Disease Prevention exams with little to no copay for individuals at risk (family/personal history, high sun exposure, or suspected precursor lesions). The article emphasizes prevention and sun safety—shade, protective clothing, wide-brim hats, UV-blocking sunglasses, and SPF 15+ sunscreen—and teaches the melanoma warning signs (A-B-C-D-E), encouraging patients to schedule yearly TRICARE exams and discuss skin changes with their providers, with CDC/NCI resources referenced.

Three Practical Steps in Your 30s to Slash Colorectal Cancer Risk
health11 days ago

Three Practical Steps in Your 30s to Slash Colorectal Cancer Risk

With colorectal cancer rising among younger adults, doctors outline three in-30s actions: eat a fiber-rich, minimally processed diet and stay physically active to maintain a healthy weight; take persistent GI symptoms seriously and discuss family history with your doctor; and consider early, proactive screening—using stool- or blood-based tests as noninvasive options alongside colonoscopy—especially if you have risk factors or a family history.

 PSA screening may cut prostate cancer deaths, but benefits are modest and conditional
health12 days ago

PSA screening may cut prostate cancer deaths, but benefits are modest and conditional

A new Cochrane review finds PSA blood testing likely reduces death from prostate cancer with moderate certainty, reporting about two fewer disease-specific deaths per 1,000 men screened across six long-term European and North American trials. The benefit is modest and depends on careful implementation, ongoing medical follow-up, and selective biopsies to minimize overdiagnosis and overtreatment; the study does not issue guidelines but supports PSA screening in appropriately selected patients.

PSA screening cuts prostate cancer deaths but benefits are modest and risks exist
health12 days ago

PSA screening cuts prostate cancer deaths but benefits are modest and risks exist

A large Cochrane review of six PSA screening trials (nearly 800,000 men) finds PSA testing can reduce prostate cancer deaths, but the absolute benefit is small (about 2 lives saved per 1,000 screened; 500 men need screening to prevent one death). Benefits emerge only with long follow-up, while many men face overdiagnosis and potential harms from treatment, such as incontinence or erectile dysfunction. The authors caution against universal screening and emphasize shared decision making, with targeted approaches for high-risk groups and ongoing development of MRI- and biomarker–based methods whose extra benefit remains uncertain.

Global review finds strong cannabis-use disorder link with major depression, but causality remains unclear
science15 days ago

Global review finds strong cannabis-use disorder link with major depression, but causality remains unclear

A global review of 55 studies involving over 3.2 million people finds a strong association between cannabis use disorder (CUD) and major depressive disorder (MDD). About 32% of people with CUD also have MDD, and over 10% of people with MDD have CUD, rates higher than in the general population. The authors caution that causality cannot be established and suggest shared risk factors or self-medication may contribute; they call for routine screening in treatment settings and note that while pharmacological options are unclear, psychological therapies show promise. The work was published in The Journal of Psychiatric Research.

GLP-1s Mask Cancer Clues, Delaying Diagnosis for Some Patients
health16 days ago

GLP-1s Mask Cancer Clues, Delaying Diagnosis for Some Patients

The New York Post’s The Thin Line reports that GLP-1 medications like Ozempic and Mounjaro can blur gastrointestinal symptoms, leading some patients and even doctors to misattribute signs to drug side effects and delay colorectal cancer screening. Personal stories, including Brooke Hinderhan’s cancer diagnosis after years on GLP-1s and Michelle Lyson’s later-stage disease, illustrate how symptoms can overlap with treatment effects. Doctors caution that red-flag signs such as rectal bleeding or significant stool changes require evaluation, and emphasize that early detection greatly improves survival, underscoring that GLP-1s are not a guaranteed safeguard against cancer or its masking effects.

Rectal Cancer: Early Warning Signs to Watch For, Especially Among Younger Adults
health28 days ago

Rectal Cancer: Early Warning Signs to Watch For, Especially Among Younger Adults

Rectal cancer often shows up with rectal bleeding and abdominal pain, but can also cause changes in bowel habits, thinner stools, fatigue, and weight loss; some people have no symptoms at all, making regular colorectal screening crucial. The article highlights rising rates of rectal cancer in people under 50, with average‑risk screening beginning at 45. Risk factors include obesity and diabetes, while lifestyle measures such as a Mediterranean-style diet, limiting red/processed meats and sugar-sweetened beverages, moderating alcohol, and maintaining regular medical care can help reduce risk. If you notice blood in stool or other GI changes, seek medical evaluation promptly.

Overdiagnosis Rises Sharply After 70 in PSA Prostate Screening, Study Finds
health28 days ago

Overdiagnosis Rises Sharply After 70 in PSA Prostate Screening, Study Finds

A UK analysis of over 400,000 men finds PSA-based prostate cancer screening has low overdiagnosis risk in men in their 50s–60s but rises sharply after 70 due to higher competing mortality; 16% of PSA-detected cancers would not become clinically relevant within 15 years at age 50, rising to 32% at 70 and 58% at 80. Consequently, screening offers little net benefit for men over 70, though MRI-guided biopsy and ongoing trials may reduce harms from overdiagnosis; decisions should be individualized, especially for older men.

Beyond smoking: debunking lung cancer myths and the case for broader screening
health28 days ago

Beyond smoking: debunking lung cancer myths and the case for broader screening

Lung cancer is not solely a smoker’s disease, with up to a quarter of cases occurring in never-smokers and risk shaped by environment, genetics, and race. While low-dose CT screening can reduce mortality, current guidelines tied to a 20-pack-year history miss many at risk, prompting NCCN and ACS to broaden criteria and programs like INSPIRE to reach more Black patients and others outside traditional thresholds. New AI tools (e.g., Sybil) show potential to predict cancer risk from a single CT and personalize screening intervals, signaling a shift toward risk-based, more inclusive screening and earlier detection to reduce disparities.

Rectal Cancer Deaths Spike in Young Adults, Study Warns
health28 days ago

Rectal Cancer Deaths Spike in Young Adults, Study Warns

A study analyzing CDC death records from 1999–2023, with machine-learning projections, shows rectal cancer mortality among adults aged 20–44 rising two to three times faster than colon cancer and widening across demographics, especially Hispanics and Western states. Researchers warn that diagnostic delays (about seven months for young patients) and symptom dismissiveness contribute to more advanced disease, suggesting screening strategies may need reevaluation to address increasing younger-onset rectal cancer.

Hidden Fifth Force: Could Solar-System Tests Unveil Cosmic Gravity Clues
science1 month ago

Hidden Fifth Force: Could Solar-System Tests Unveil Cosmic Gravity Clues

A NASA physicist argues that a proposed fifth force—potentially screened in dense environments—could explain cosmic acceleration while staying hidden in the Solar System; current observations align with general relativity locally, so any breakthrough would require a dedicated, falsifiable mission built on precise predictions and guided by cosmological survey data to bridge local gravity tests with the large-scale universe.

Multi-Cancer Blood Tests: Promise Hangs in the Balance
health1 month ago

Multi-Cancer Blood Tests: Promise Hangs in the Balance

Researchers are pursuing multi-cancer blood tests using DNA fragments and AI, with early signals like Mercury showing notable sensitivity across several cancers. Yet the largest Galleri trial did not reduce advanced cancer diagnoses or provide clear survival benefits, and test accuracy varies by cancer type. Experts say a universal one-test solution is unlikely; a portfolio of targeted tests and longer follow-up to prove life-saving value and enable insurer coverage is more plausible before routine use.

Education gap linked to rising colorectal cancer deaths in young adults
health1 month ago

Education gap linked to rising colorectal cancer deaths in young adults

An American Cancer Society analysis of 101,000 colorectal cancer deaths in people aged 25–49 (1994–2023) shows mortality rising among those without a bachelor’s degree while remaining flat for graduates, likely due to socioeconomic-linked risk factors such as obesity, inactivity, smoking and diet. Researchers could not determine exact causes from death certificates, but note earlier screening guidelines—lowered to age 45 in 2021—and that colorectal cancer is now the leading cancer killer for men under 50 and a top killer for women in the same age group.